Top articles since 2015

Rank Title Journal Year PubWeight™‹?›
1 Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem 2015 158.65
2 Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Transl Androl Urol 2016 66.58
3 Cancer statistics, 2015. CA Cancer J Clin 2015 57.51
4 Global cancer statistics, 2012. CA Cancer J Clin 2015 53.52
5 Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2015 40.89
6 The Cambridge Structural Database. Acta Crystallogr B Struct Sci Cryst Eng Mater 2016 34.37
7 SHELXT - integrated space-group and crystal-structure determination. Acta Crystallogr A Found Adv 2015 33.64
8 Cancer statistics, 2016. CA Cancer J Clin 2016 32.95
9 Towards a unified approach in the modeling of fibrosis: A review with research perspectives. Phys Life Rev 2016 24.96
10 Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 2015 21.42
11 The SCARE Statement: Consensus-based surgical case report guidelines. Int J Surg 2016 20.35
12 The Now-or-Never bottleneck: A fundamental constraint on language. Behav Brain Sci 2015 19.27
13 A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015 19.14
14 The quartet theory of human emotions: An integrative and neurofunctional model. Phys Life Rev 2015 18.83
15 Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 2015 18.66
16 Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020 18.57
17 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 18.32
18 The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016 17.49
19 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015 16.87
20 A new initiative on precision medicine. N Engl J Med 2015 16.03
21 Bilingual advantages in executive functioning either do not exist or are restricted to very specific and undetermined circumstances. Cortex 2015 15.27
22 Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015 15.06
23 Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 14.88
24 limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015 14.81
25 Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med 2015 14.71
26 MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol 2016 14.16
27 Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med 2015 13.90
28 PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med 2015 13.08
29 Cancer statistics in China, 2015. CA Cancer J Clin 2016 12.92
30 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016 12.86
31 A global reference for human genetic variation. Nature 2015 12.85
32 PLATON SQUEEZE: a tool for the calculation of the disordered solvent contribution to the calculated structure factors. Acta Crystallogr C Struct Chem 2015 12.77
33 Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med 2015 12.74
34 Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015 12.70
35 Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 2015 12.61
36 Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med 2015 12.54
37 Deciphering death: a commentary on Gompertz (1825) 'On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies'. Philos Trans R Soc Lond B Biol Sci 2015 12.50
38 Towards a Computational Comparative Neuroprimatology: Framing the language-ready brain. Phys Life Rev 2015 12.40
39 PSYCHOLOGY. Estimating the reproducibility of psychological science. Science 2015 12.18
40 Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015 12.06
41 Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015 12.05
42 Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med 2015 11.98
43 Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 2015 11.89
44 Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016 11.83
45 Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015 11.60
46 The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev 2015 11.49
47 Human behaviours in evacuation crowd dynamics: From modelling to "big data" toward crisis management. Phys Life Rev 2016 11.16
48 Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015 11.05
49 A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med 2015 11.05
50 Universal scaling for the dilemma strength in evolutionary games. Phys Life Rev 2015 11.01
Next 50